<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Canadian Pharmacy Blog &#187; Glucose Control</title>
	<atom:link href="http://annpharmacy.com/blog/tag/glucose-control/feed" rel="self" type="application/rss+xml" />
	<link>http://annpharmacy.com/blog</link>
	<description>Health, Diseases, Drugs &#38; medications, Online canadian pharmacy</description>
	<lastBuildDate>Wed, 25 May 2011 13:02:23 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
		<item>
		<title>Pramlintide for Glucose Control</title>
		<link>http://annpharmacy.com/blog/anti-diabetic/pramlintide-for-glucose-control.html</link>
		<comments>http://annpharmacy.com/blog/anti-diabetic/pramlintide-for-glucose-control.html#comments</comments>
		<pubDate>Wed, 13 Oct 2010 05:33:56 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Diabetic]]></category>
		<category><![CDATA[Glucose Control]]></category>
		<category><![CDATA[Pramlintide]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=848</guid>
		<description><![CDATA[Amylin Pharmaceuticals, Inc., has announced the FDA&#8217;s approval of pram-lintide acetate (Symlin®) injection to be used in conjunction with insulin to treat type-1 and type-2 diabetes. This product is to be used at mealtime in diabetic patients who have been unable to achieve desired glucose control despite optimal insulin therapy. The self-administered injection causes less [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/anti-diabetic/pramlintide-for-glucose-control.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Glucose Control with Sitagliptin Phosphate</title>
		<link>http://annpharmacy.com/blog/anti-diabetic/glucose-control-with-sitagliptin-phosphate.html</link>
		<comments>http://annpharmacy.com/blog/anti-diabetic/glucose-control-with-sitagliptin-phosphate.html#comments</comments>
		<pubDate>Sun, 25 Jul 2010 16:32:17 +0000</pubDate>
		<dc:creator>John Mitchell</dc:creator>
				<category><![CDATA[Anti-Diabetic]]></category>
		<category><![CDATA[Glucose Control]]></category>
		<category><![CDATA[Sitagliptin Phosphate]]></category>

		<guid isPermaLink="false">http://annpharmacy.com/blog/?p=454</guid>
		<description><![CDATA[Sitagliptin generic phosphate (Januvia, Merck), the first diabetes treatment approved in a new class of drugs known as DDP-4 inhibitors, enhances the body&#8217;s own ability to lower elevated blood glucose levels. The FDA approved the tablets for use in addition to diet and exercise to improve blood sugar levels in patients with type-2 diabetes; the [...]]]></description>
		<wfw:commentRss>http://annpharmacy.com/blog/anti-diabetic/glucose-control-with-sitagliptin-phosphate.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

